Amendment Statement of Principles concerning Guillain-Barre syndrome (Reasonable Hypothesis) (No. 57 of 2021)

Administered by Department of Veterans' Affairs

Legislation au F2021L00483 Not in force Legislative Instrument

Legislation content

EXPLANATORY STATEMENT

 

AMENDMENT Statement of Principles concerning

GUILLAIN-BARRE SYNDROME

(REASONABLE HYPOTHESIS) (NO. 57 OF 2021)

 

VETERANS' ENTITLEMENTS ACT 1986

MILITARY REHABILITATION AND COMPENSATION ACT 2004

 

  1. This is the Explanatory Statement to the Amendment Statement of Principles concerning Guillain-Barre syndrome (Reasonable Hypothesis) (No. 57 of 2021).

Background

2.             The Repatriation Medical Authority (the Authority) has determined, under subsections 196B(2) and (8) of the Veterans' Entitlements Act 1986 (the VEA), Amendment Statement of Principles concerning Guillain-Barre syndrome (Reasonable Hypothesis) (No. 57 of 2021).

3.             This Instrument amends Statement of Principles concerning Guillain-Barre syndrome (Reasonable Hypothesis) (No. 23 of 2018) (Federal Register of Legislation No. F2018L00187) by:

  • revising the factor in subsection 9(1) concerning 'having an infection from the specified list of infections', for clinical onset only; and
  • revising the definition of 'specified list of infections' in Schedule 1 - Dictionary.

Day of Commencement

4.             This Instrument also specifies a day of commencement for the amendment in accordance with subsection 12(3) of the Legislation Act 2003.

Consultation

5.             Prior to determining this Instrument, the Authority advertised its intention to undertake an investigation in relation to Guillain-Barre syndrome in the Government Notices Gazette of 5 January 2021, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants.  The Authority invited submissions from the Repatriation Commission, the Military Rehabilitation and Compensation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field.  No submissions were received for consideration by the Authority in relation to the investigation.

Human Rights

6.             This instrument is compatible with the Human Rights and Freedoms recognised or declared in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011. A Statement of Compatibility with Human Rights follows.

Finalisation of Investigation

7.             The determining of this Instrument finalises the investigation in relation to
Guillain-Barre syndrome as advertised in the Government Notices Gazette of 5 January 2021.

References

8.             A list of references relating to the above condition is available on the Authority’s website at: www.rma.gov.au. Any other document referred to in this Statement of Principles is available on request to the Repatriation Medical Authority at the following address:

              

Email:    info@rma.gov.au

Post:      The Registrar

Repatriation Medical Authority

GPO Box 1014

BRISBANE    QLD    4001

 


Statement of Compatibility with Human Rights

(Prepared in accordance with Part 3 of the Human Rights (Parliamentary Scrutiny) Act 2011)

 

Instrument No.:   Amendment Statement of Principles No. 57 of 2021

Kind of Injury, Disease or Death: Guillain-Barre syndrome

 

This Legislative Instrument is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.

Overview of the Legislative Instrument

1. This Legislative Instrument is determined pursuant to subsection 196B(2) of the Veterans' Entitlements Act 1986 (the VEA) for the purposes of the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).  Part XIA of the VEA requires the determination of these instruments outlining the factors connecting particular kinds of injury, disease or death with service such being determined solely on the available sound medical-scientific evidence.

2. This Legislative Instrument:-

  • facilitates claimants in making, and the Repatriation Commission and the Military Rehabilitation and Compensation Commission in assessing, claims under the VEA and the MRCA respectively, by specifying the circumstances in which medical treatment and compensation can be extended to eligible persons who have Guillain-Barre syndrome;
  • facilitates the review of such decisions by the Veterans' Review Board and the Administrative Appeals Tribunal;
  • revises a factor which the current sound medical-scientific evidence indicates must as a minimum exist, before it can be said that a reasonable hypothesis has been raised, connecting Guillain-Barre syndrome with the circumstances of eligible service rendered by a person;
  • amends Instrument No. 23 of 2018; and
  • reflects developments in the available sound medical-scientific evidence concerning Guillain-Barre syndrome which have occurred since that earlier instrument was determined. 

3. The Instrument is assessed as being a technical instrument which improves the medico-scientific quality of outcomes under the VEA and the MRCA. 

Human Rights Implications

4. This Legislative Instrument does not derogate from any human rights. It promotes the human rights of veterans, current and former Defence Force members as well as other persons such as their dependents, including:

  • the right to social security (Art 9, International Covenant on Economic, Social and Cultural Rights; Art 26, Convention on the Rights of the Child and Art 28, Convention on the Rights of Persons with Disabilities) by helping to ensure that the qualifying conditions for the benefit are 'reasonable, proportionate and transparent'[1];
  • the right to an adequate standard of living (Art 11, ICSECR; Art 27, CRC and Art 28, CRPD) by facilitating the assessment and determination of social security benefits;
  • the right to the enjoyment of the highest attainable standard of physical and mental health (Art 12, ICSECR and Art 25, CRPD), by facilitating the assessment and determination of compensation and benefits in relation to the treatment and rehabilitation of veterans and Defence Force members;
  • the rights of persons with disabilities by facilitating the determination of claims relating to treatment and rehabilitation (Art 26, CRPD); and
  • ensuring that those rights "will be exercised without discrimination of any kind as to race, colour, sex, language, religion, political or other opinion, national or social origin, property, birth or other status" (Art 2, ICESCR).

Conclusion

This Legislative Instrument is compatible with human rights as it does not derogate from and promotes a number of human rights.

 

Repatriation Medical Authority

 

 

 

 

 

 

[1] In General Comment No. 19 (The right to social security), the Committee on Economic, Social and Cultural Rights said (at paragraph 24) this to be one of the elements of ensuring accessibility to social security.

Overview

The Amendment Statement of Principles concerning Guillain-Barre syndrome (Reasonable Hypothesis) (No. 57 of 2021) was determined by the Repatriation Medical Authority under the Veterans' Entitlements Act 1986. This legislative instrument aims to facilitate the assessment and determination of claims for medical treatment and compensation related to Guillain-Barre syndrome for eligible veterans and Defence Force members. It revises the previous Statement of Principles concerning Guillain-Barre syndrome (Reasonable Hypothesis) (No. 23 of 2018) by updating the medical-scientific evidence and criteria for assessing claims. The objective of this amendment is to ensure that the qualifying conditions for benefits are reasonable, proportionate, and transparent, while promoting human rights such as the right to social security and the highest attainable standard of physical and mental health. This Legislative Instrument is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011. It promotes the human rights of veterans, current and former Defence Force members, and their dependents by ensuring non-discriminatory access to social security and healthcare benefits. The Instrument does not derogate from any human rights and is assessed as a technical instrument that improves the medico-scientific quality of outcomes under the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004.

Scope and Application

The Amendment Statement of Principles concerning Guillain-Barre syndrome (Reasonable Hypothesis) (No. 57 of 2021) amends the Statement of Principles concerning Guillain-Barre syndrome (Reasonable Hypothesis) (No. 23 of 2018) under the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. This amendment applies to veterans, current and former members of the Defence Force, and potentially their dependents who have been diagnosed with Guillain-Barre syndrome. The legislative instrument facilitates the process of making and assessing claims for medical treatment and compensation related to this condition. It revises certain factors that must exist for a reasonable hypothesis to connect the syndrome with service circumstances, reflecting recent developments in medical-scientific evidence. The amendment applies on a national level, governed by Commonwealth legislation, and is designed to ensure the assessment of claims is reasonable, proportionate, and transparent, thereby promoting various human rights, including the right to social security and adequate standard of living. The amendment does not specify any exclusions or thresholds and does not extend or restrict application beyond what is specified in the instrument itself.

Key Provisions

The main operative sections of the Amendment Statement of Principles concerning Guillain-Barre syndrome (Reasonable Hypothesis) (No. 57 of 2021) amend the existing Statement of Principles concerning Guillain-Barre syndrome (Reasonable Hypothesis) (No. 23 of 2018). Specifically, the amendment revises the factor in subsection 9(1) concerning 'having an infection from the specified list of infections' for clinical onset only (section 3). Additionally, it revises the definition of 'specified list of infections' in Schedule 1 - Dictionary (section 3). The document also specifies a day of commencement for the amendment in accordance with subsection 12(3) of the Legislation Act 2003 (section 4). The obligations and requirements imposed by the Act primarily concern the Repatriation Medical Authority (the Authority) and the Repatriation Commission and the Military Rehabilitation and Compensation Commission. The Authority must determine the amendment in line with subsections 196B(2) and (8) of the Veterans' Entitlements Act 1986 (VEA) and ensure the instrument is compatible with human rights as outlined in the Human Rights (Parliamentary Scrutiny) Act 2011. The Repatriation Commission and the Military Rehabilitation and Compensation Commission must assess claims under the VEA and the Military Rehabilitation and Compensation Act 2004 respectively, using the revised Statement of Principles to determine eligibility for benefits related to Guillain-Barre syndrome. For breaches of the provisions outlined in this instrument, there are no specific criminal or civil penalties mentioned within the explanatory statement. However, non-compliance with the human rights compatibility requirements could potentially lead to legal challenges under the Human Rights (Parliamentary Scrutiny) Act 2011. It is important for all parties involved to adhere to the provisions to ensure the proper administration of veterans' entitlements and the fair assessment of claims related to Guillain-Barre syndrome.

Legal classification tags

Area of Law
Veterans' Law
Instrument
Regulation
Concepts
Definitions & Interpretation
Reporting & Disclosure Obligations
Rights & Protections

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.